BioMarin Pharmaceutical Inc. (BMRN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Core Viewpoint - BioMarin is focused on transforming its operations and setting a path for significant growth, with an emphasis on innovation in genetically defined conditions [2]. Group 1: Company Overview - BioMarin is recognized as a leader in genetically defined conditions, boasting an impressive track record of innovation [3]. - The company has developed 6 first-in-disease treatments and numerous best-in-disease treatments, showcasing its commitment to addressing unmet medical needs [3]. - BioMarin has built substantial capabilities over nearly 25 years, including a geographic footprint that spans 80 countries [3].